PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
MGUS: Can Diet, Exercise and Supplements Reduce the Risk of Multiple Myeloma?If you have MGUS, “watch and wait” does not have to mean “do nothing.” But it is important to distinguish between therapies proven to treat MGUS and lifestyle or nutritional strategies that may improve overall health or potentially influence progression risk.
For most people with MGUS, conventional management therefore consists of risk assessment followed by periodic monitoring rather than immediate treatment.
Is there anything I can safely do while my hematologist monitors my MGUS?
The answer requires some nuance.
There is currently no supplement, diet, or lifestyle intervention proven in large randomized clinical trials to prevent MGUS from becoming multiple myeloma.
However, emerging evidence suggests that metabolic health, body weight, diet, physical activity, and possibly certain nutritional compounds may deserve attention.
The goal should not be to replace appropriate medical monitoring. The goal is to combine monitoring with reasonable, low-risk strategies for improving your overall health.
My experience as a long-term myeloma survivor is that MGUS and SMM patients do not want to “watch and wait” for their blood disorder to become full-blown multiple myeloma. At the same time, newly diagnosed MGUS and SMMers don’t want to live through toxic chemotherapy with all of the side effects.
To learn more about the evidence-based protocols you can follow to prevent your Pre-Myeloma from becoming Multiple Myeloma, please watch the short video below:
If you have a question, scroll down the page, post a question or a comment, and I will reply to you ASAP.
Thanks,
David Emerson
MM Survivor
MM Cancer Coach
Director PeopleBeatingCancer
Diagnosed With MGUS? Why You Shouldn’t Just Watch and Wait
and, when appropriate, imaging or bone-marrow findings.
The International Myeloma Working Group has historically identified low-risk MGUS as IgG MGUS with an M-protein below 1.5 g/dL and a normal free-light-chain ratio.
Patients with additional risk factors generally require closer follow-up.
An important distinction: MGUS is not smoldering myeloma
MGUS and smoldering multiple myeloma (SMM) are related, but they should not be treated as interchangeable diagnoses.
Smoldering myeloma generally involves a larger plasma-cell burden and carries a substantially greater risk of progression.
That distinction has become even more important because research into early treatment of higher-risk smoldering multiple myeloma has advanced considerably.
Someone with MGUS should therefore know exactly where he or she falls on the plasma-cell-disorder spectrum.
“Watch and Wait” Should Really Mean “Monitor and Manage Risk”
I prefer the phrase active monitoring.
Your hematologist monitors the clone.
You can concentrate on the health factors that you can influence.
That doesn’t mean that lifestyle changes have been proven to eliminate MGUS. They haven’t.
It means using the observation period productively.
1. Maintain a Healthy Body Weight
Among the most interesting modifiable risk factors is excess body weight.
Population research has associated obesity and excess body mass with an increased risk of multiple myeloma. Research specifically examining people with MGUS has also suggested an association between excess weight and subsequent progression.
A population-based study reported that higher midlife BMI was associated with increased progression from MGUS/light-chain MGUS to multiple myeloma or another lymphoproliferative disorder.
More recent research has examined cumulative exposure to excess BMI after an MGUS diagnosis as another potential factor in progression.
This does not prove that losing weight will prevent multiple myeloma.
But maintaining a healthy weight has so many cardiovascular, metabolic and cancer-related benefits that it is a reasonable part of an MGUS survivorship strategy.
2. Exercise Regularly
Exercise has not been proven in a clinical trial to stop MGUS progression.
It nevertheless offers substantial benefits that matter to people living with a precancerous condition:
better cardiovascular health,
improved insulin sensitivity,
maintenance of muscle,
improved bone health,
reduced inflammation,
better balance and mobility,
improved sleep,
and improved quality of life.
Think of exercise as health maintenance rather than MGUS chemotherapy.
For many people, regular walking plus appropriate resistance exercise is an excellent place to begin.
3. Eat for Metabolic and Cardiovascular Health
There is no established “MGUS diet.”
I would be skeptical of anyone who tells you otherwise.
A reasonable dietary pattern emphasizes:
vegetables and fruit,
legumes,
whole grains,
nuts and seeds,
fish and other healthy protein sources,
healthy fats such as olive oil,
adequate fiber,
and relatively little ultra-processed food.
This resembles the Mediterranean-style dietary pattern associated with cardiovascular and metabolic benefits.
The rationale is not that individual foods “kill MGUS.”
Rather, nutrition can help improve body weight, glucose regulation, cardiovascular health, and inflammatory status—factors that become increasingly important as we age.
4. What About Curcumin?
Curcumin deserves special attention because, unlike many supplements promoted for MGUS, it has actually been studied in people with MGUS and smoldering myeloma.
A small randomized, double-blind, placebo-controlled crossover study included 36 patients—19 with MGUS and 17 with smoldering multiple myeloma.
Researchers evaluated 4 grams of curcumin daily, followed by an optional 8-gram extension.
They reported changes in several laboratory markers, including:
free-light-chain ratio,
involved free light chains,
difference between clonal and nonclonal light chains,
and a marker of bone resorption.
The researchers concluded that curcumin might have the potential to slow the disease process.
That word might is important.
This was a small study. It did not demonstrate that curcumin prevents MGUS from progressing to multiple myeloma or improves survival.
An earlier clinical study involving 26 MGUS patients also reported reductions in paraprotein and bone-resorption markers among some participants.
These findings make curcumin interesting.
They do not make curcumin an established MGUS treatment.
Anyone considering high-dose curcumin should discuss it with a physician or pharmacist, particularly if taking anticoagulants/antiplatelet medications, undergoing surgery, experiencing gallbladder problems, or taking other medications or supplements that could interact with it.
5. Supplements: Think “Evidence-Informed,” Not “Cancer Cure”
Laboratory studies have identified numerous compounds capable of influencing biological pathways involved in multiple myeloma cells.
That is interesting research.
But killing myeloma cells in a laboratory dish is not the same thing as preventing MGUS from progressing in a human being.
Evidence can be thought of as a hierarchy:
Evidence
What it tells us
Laboratory studies
A compound may affect myeloma cells or relevant pathways
Animal studies
Biological effects may occur in a living organism
Observational human studies
An association may exist
Small human intervention trials
A treatment may affect biomarkers
Randomized clinical trials
Stronger evidence of clinical benefit
Progression/survival data
Evidence that patients actually experience better outcomes
This distinction is particularly important when evaluating supplements.
The PeopleBeatingCancer Evidence Rating
Strategy
Evidence for MGUS
PBC Rating
Risk-stratified medical monitoring
Strong guideline/observational evidence
Strong
Maintaining healthy body weight
Observational evidence linking obesity/excess BMI with progression risk
Moderate
Regular exercise
Strong general-health evidence; limited direct MGUS progression evidence
Moderate for overall health / Limited for MGUS progression
Mediterranean-style whole-food diet
Strong cardiometabolic evidence; limited direct MGUS evidence
Moderate for overall health / Limited for MGUS progression
Curcumin
Small human MGUS/SMM intervention studies
Preliminary
Other anti-myeloma supplements
Primarily laboratory/preclinical evidence
Limited/Experimental
PBC interpretation: An evidence rating describes the strength of the available research. It does not mean that a therapy has been proven to prevent or treat multiple myeloma.
What Does “Metronomic Therapy” Mean?
The original version of this article discussed metronomic chemotherapy.
That term has a specific meaning in oncology.
Metronomic chemotherapy generally refers to the frequent administration of conventional anticancer drugs at relatively low doses with few or no prolonged drug-free intervals. Researchers have investigated the strategy partly because of its potential effects on tumor angiogenesis and the tumor microenvironment.
That concept is scientifically interesting.
But I would no longer describe diet, exercise or supplements as “metronomic chemotherapy.”
They are better described as continuous lifestyle and complementary interventions.
That distinction matters because none of these interventions should be assumed to produce the same biological effects as chemotherapy.
What I Would Do After an MGUS Diagnosis
If I were newly diagnosed with MGUS today, I would think about the diagnosis in two parallel tracks.
Track One: Monitor the MGUS carefully.
I would want to understand:
my M-spike,
immunoglobulin subtype,
kappa and lambda free light chains,
free-light-chain ratio,
CBC,
calcium,
kidney function,
and my overall risk category.
I would also keep copies of my laboratory results so that I could watch trends rather than individual readings.
Track Two: Improve everything I reasonably can control.
I would focus on:
maintaining a healthy weight,
exercising regularly,
eating a largely whole-food Mediterranean-style diet,
protecting cardiovascular health,
maintaining bone health,
sleeping well,
avoiding tobacco,
and discussing evidence-based supplements with my healthcare team.
None of these strategies guarantees that MGUS will remain stable.
But they can improve health while you are being monitored.
My Perspective as a Long-Term Multiple Myeloma Survivor
I was diagnosed with multiple myeloma in the 1990s and have lived with the consequences of both cancer and cancer treatment for decades.
That experience shapes the way I think about precursor conditions such as MGUS.
I don’t believe that patients should panic and treat MGUS as though they already have multiple myeloma.
I also don’t believe that observation has to mean ignoring your health until something changes.
There is a large middle ground between those two approaches.
Monitor the disease. Understand your risk. Improve the health factors you can influence. Follow the research.
That is a much more accurate way to describe what I once called “continuous, metronomic, non-toxic therapy.”
When Should an MGUS Patient Contact Their Doctor?
Do not assume that every new symptom is caused by MGUS.
But contact your healthcare team if you develop persistent or unexplained:
bone pain,
worsening fatigue or weakness,
anemia,
kidney problems,
elevated calcium,
unexplained weight loss,
recurrent infections,
neuropathy,
or a significant change in monoclonal-protein/free-light-chain measurements.
These findings do not automatically mean multiple myeloma, but they may justify further evaluation.
The Bottom Line
MGUS usually does not require treatment. It requires appropriate risk stratification and monitoring.
There is currently no diet, supplement, or lifestyle program proven to prevent MGUS from progressing to multiple myeloma.
But that doesn’t mean there is nothing you can do.
Research increasingly supports paying attention to metabolic health and body weight, while exercise and a healthy dietary pattern provide broad health benefits. Curcumin has produced intriguing biomarker findings in small human MGUS/SMM studies, but the evidence remains preliminary.
For me, the most sensible approach is:
Monitor what you cannot control. Improve what you can control. And don’t confuse promising research with proven treatment.
That is the approach I wish I had understood when I first entered the world of pre-myeloma and multiple myeloma.
Research links
I would replace the old metronomic-chemotherapy excerpt with these much more relevant sources:
HI david, Thanks for all that you do!! It was wonderful to find your pages and the work you do is so good. It really helps. And congratulations on your 23 years!!
I was diagnosed last year Nov with MGUS. My “M spike” varies in the interim from 2.2 (January) to 1.6 (April) and the last reading was 1.9. I have gone back over my approaches between January and April and have removed somethings and am putting back others. I am 60 in September. I have no symptoms really except low immunity and aches and tiredness.
My questions are: do you still have an “m spike” after all this time?
Have you ever used colema board for serious colon cleansing to detoxify?
Which package would you advise for me with my current condition?
I am especially interested in the things that I must NOT do with MGUS. I am on turmeric (fresh) . Alkali diet. I am replacing black seed oil, and castor oil packs and meditation which I lost track of after the lower reading in April. I got a bit in denial about it. It is interesting to me how it fluctuates. I mean if it fluctuates then they are wrong to say it always increases by year..right? Thanks David, I hope you are really well and happy, Gillian
I am sorry to read of your MGUS diagnosis. You are correct. An m-spike that fluctuates indicates that you are not progressing to frank MM. This is good. I know of 2 pre-MM people who have remained pre-MM for over 18 years now.
I take an SPEP blood test to monitor possible MM. The test monitors kappa and lambda FL chains but not an m-spike. As long as my kappa and lambda and K/L ratio levels are in the “normal” ranges I am happy.
I detoxify through different methods including colonics, whole body hyperthermia, juicing, others but I do not use a colema board. I have never researched and developed a list of what NOT to do for pre-MM only a list of evidence-based therapies that pre-MM people should do to reduce their risk of full blown MM.
A good example is plain curcumin/turmeric versus those formulas that have been shown to be more bioavailable meaning more absorbable in the blood. I will link and article explaining these formulas below.
The basic pre-MM program linked below will explain what I think MGUS patients should do.
